Cite
HARVARD Citation
Ma, J. et al. (n.d.). A POST‐MARKETING SURVEILLANCE STUDY OF 703 PATIENTS TREATED WITH CHIDAMIDE FOR PERIPHERAL T‐CELL LYMPHOMA (PTCL) IN CHINA. HDAC STUDY GROUP OF UNION FOR CHINA LYMPHOMA INVESTIGATORS (UCLI). Hematological oncology. pp. 250-251. [Online].